AQUIPTA 10 mg
AQUIPTA 10 mg is a medicine authorised by Swissmedic under authorisation number 69128. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 March 2024 and the authorisation is limited until 05 March 2029. ATC code N02CD07 places the medicine in the group Analgesics.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | AQUIPTA 10 mg, Tabletten | B | 06 March 2024 |
| 2 | AQUIPTA 60 mg, Tabletten | B | 06 March 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | N02CD07 | 02.05.1. | B |
| 3 | 28 | Tablette(n) | N02CD07 | 02.05.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is AQUIPTA 10 mg authorised in Switzerland?
Yes. AQUIPTA 10 mg is authorised by Swissmedic under authorisation number 69128, data as of 01 September 2026. The authorisation is limited until 05 March 2029.
Which dispensing category does AQUIPTA 10 mg have?
AQUIPTA 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of AQUIPTA 10 mg?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.